144 related articles for article (PubMed ID: 30361826)
1. Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report.
Kaur E; Goda JS; Ghorai A; Salunkhe S; Shetty P; Moiyadi AV; Sridhar E; Mahajan A; Jalali R; Dutt S
Cell Oncol (Dordr); 2019 Feb; 42(1):107-116. PubMed ID: 30361826
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence.
Kaur E; Rajendra J; Jadhav S; Shridhar E; Goda JS; Moiyadi A; Dutt S
Carcinogenesis; 2015 Jun; 36(6):685-95. PubMed ID: 25863126
[TBL] [Abstract][Full Text] [Related]
3. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture.
Tribius S; Pidel A; Casper D
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):511-23. PubMed ID: 11380241
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress.
Kaur E; Ketkar M; Dutt S
Med Oncol; 2022 Feb; 39(5):50. PubMed ID: 35150325
[TBL] [Abstract][Full Text] [Related]
5. MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated.
Guo P; Lan J; Ge J; Nie Q; Guo L; Qiu Y; Mao Q
Exp Cell Res; 2014 Jan; 320(2):200-8. PubMed ID: 24211747
[TBL] [Abstract][Full Text] [Related]
6. ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.
Guo Q; Guo P; Mao Q; Lan J; Lin Y; Jiang J; Qiu Y
Med Oncol; 2013 Mar; 30(1):325. PubMed ID: 23377983
[TBL] [Abstract][Full Text] [Related]
7. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
8. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
9. MiR-224 expression increases radiation sensitivity of glioblastoma cells.
Upraity S; Kazi S; Padul V; Shirsat NV
Biochem Biophys Res Commun; 2014 May; 448(2):225-30. PubMed ID: 24785373
[TBL] [Abstract][Full Text] [Related]
10. Sustained inhibition of PARP-1 activity delays glioblastoma recurrence by enhancing radiation-induced senescence.
Ghorai A; Mahaddalkar T; Thorat R; Dutt S
Cancer Lett; 2020 Oct; 490():44-53. PubMed ID: 32645394
[TBL] [Abstract][Full Text] [Related]
11. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma.
Zhou W; Yao Y; Scott AJ; Wilder-Romans K; Dresser JJ; Werner CK; Sun H; Pratt D; Sajjakulnukit P; Zhao SG; Davis M; Nelson BS; Halbrook CJ; Zhang L; Gatto F; Umemura Y; Walker AK; Kachman M; Sarkaria JN; Xiong J; Morgan MA; Rehemtualla A; Castro MG; Lowenstein P; Chandrasekaran S; Lawrence TS; Lyssiotis CA; Wahl DR
Nat Commun; 2020 Jul; 11(1):3811. PubMed ID: 32732914
[TBL] [Abstract][Full Text] [Related]
12. Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells.
Tang Z; Dokic I; Knoll M; Ciamarone F; Schwager C; Klein C; Cebulla G; Hoffmann DC; Schlegel J; Seidel P; Rutenberg C; Brons S; Herold-Mende C; Wick W; Debus J; Lemke D; Abdollahi A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):499-513. PubMed ID: 34534627
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 and p21 in primary glioblastomas.
Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
[TBL] [Abstract][Full Text] [Related]
14. Approaches to sensitizing glioblastoma to radiotherapy: use of lentiviral vectors.
Chuah TL; Walker DG; Wei M; Scott S; Lavin MF
Int J Oncol; 2012 Jun; 40(6):1963-9. PubMed ID: 22447336
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
16. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.
Rajendra J; Datta KK; Ud Din Farooqee SB; Thorat R; Kumar K; Gardi N; Kaur E; Nair J; Salunkhe S; Patkar K; Desai S; Goda JS; Moiyadi A; Dutt A; Venkatraman P; Gowda H; Dutt S
Oncotarget; 2018 Jun; 9(45):27667-27681. PubMed ID: 29963228
[TBL] [Abstract][Full Text] [Related]
17. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
[TBL] [Abstract][Full Text] [Related]
18. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
[TBL] [Abstract][Full Text] [Related]
19. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment.
Burnet NG; Jena R; Jefferies SJ; Stenning SP; Kirkby NF
Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):93-103. PubMed ID: 16523808
[TBL] [Abstract][Full Text] [Related]
20. Expression of TMEM59L associated with radiosensitive in glioblastoma.
Gao D; Wang P; Zhi L; Sun S; Qiu X; Liu Y
J Radiat Res; 2023 Sep; 64(5):833-841. PubMed ID: 37439405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
